The current evidence of statin use affecting glioblastoma prognosis.

Cholesterol-lowering statins have been postulated to improve cancer outcomes by many unconfirmed mechanisms. The prognosis of glioblastoma (GBM) remains dismal, and there is a paucity of evidence regarding the potential for preoperative statins to exert a benefit upon prognosis. In light of a recent report, the current evidence in the literature regarding statin use affecting GBM prognosis is discussed.